Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution
Organogenesis Holdings Inc. - Class A (ORGO)
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
CANTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Organogenesis, a leading regenerative medicine company, today announced it has received U.S. Food and Drug Administration (FDA) 510k Clearance for PuraPly MZ, a brand extension to the PuraPly product portfolio. PuraPly MZ leverages the innovative properties of our PuraPly technology engineered into a micronized (powdered) form to provide surgeons with an option for complex surgical wounds. “Securing FDA Clearance for PuraPly MZ is a significant milestone for the company as we continue to expand into the surgical and sports medicine market,” said Gary S. Gillheeney, Sr., President and chief executive officer of Organogenesis. “We are very pleased to provide surgeons addressing complex surgical wounds with access to this extension of our widely used PuraPly technology. This new solution demonstrates Organogenesis’s commitment to delivering innovative advanced technologies that improve surgical outcomes and patient experience.” Of the
Show less
Read more
Impact Snapshot
Event Time:
ORGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORGO alerts
High impacting Organogenesis Holdings Inc. - Class A news events
Weekly update
A roundup of the hottest topics
ORGO
News
- Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024GlobeNewswire
- Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case [Yahoo! Finance]Yahoo! Finance
- Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseGlobeNewswire
- Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Organogenesis Holdings Inc. (NASDAQ: ORGO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.MarketBeat
ORGO
Earnings
- 2/29/24 - Beat
ORGO
Sec Filings
- 4/29/24 - Form 3
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- ORGO's page on the SEC website